A Phase III, randomized, open‐label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy

David J. Hetzel(South Australia Pathology), Lee F. Allen(AMAG Pharmaceuticals (United States)), Audrone Urboniene(Hospital of Lithuanian University of Health Sciences Kaunas Clinics), William Strauss(AMAG Pharmaceuticals (United States)), Kristine Bernard(AMAG Pharmaceuticals (United States)), Zhu Li(Tianjin Infectious Diseases Hospital)
American Journal of Hematology
March 18, 2014
Cited by 78


Related Papers